We haven’t prepared a plain language version of this yet

We haven’t created a plain language version of this legislation yet. We’re working through New Zealand’s laws to make them more accessible to everyone, focusing on areas that impact the most people first.

If you’d like to see this particular legislation explained in plain language, please email us at hello@ackama.com with the subject “Plain language law” and mention this page — we’ll be happy to add it to our priority list.

Request a plain language version

Part 2Key roles and health documents
Ministerial powers

66Restrictions on directions under section 103 of Crown Entities Act 2004

  1. Repealed
  2. No direction may be given to Pharmac under section 103 of the Crown Entities Act 2004 that would—

  3. require Pharmac to purchase a pharmaceutical from a particular source or at a particular price; or
    1. provide any pharmaceutical or pharmaceutical subsidy or other benefit to a named individual.
      1. No direction may be given to NZBOS under section 103 of the Crown Entities Act 2004 unless it concerns—

      2. NZBOS’s role in providing oversight and clinical governance of the organ donation system and in providing support to the transplantation system; or
        1. protecting the gift status, donation, collection, processing, and supply of blood or controlled human substances (as defined in section 55 of the Human Tissue Act 2008); or
          1. withdrawal of contaminated blood or contaminated controlled human substances from supply.
            Notes
            • Section 66(1): repealed, on , by section 33 of the Pae Ora (Disestablishment of Māori Health Authority) Amendment Act 2024 (2024 No 5).